Back to search

France· FR:69770042

ELUCIREM 0,5 mmol/mL, solution injectable

A gadopiclenol product containing gadopiclénol, registered in France by GUERBET. The same ATC class is registered in 13 of our 19 countries.

ATC V08CA12

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedELUCIREM 0,5 mmol/mL, solution inject…ATCV08CA12REGISTER NO.FR:69770042PACKS LISTED7CHECKEDSeptember 12, 2026

Where it is registered

Gadopiclenol is registered in 13 of 19 countries.

Countries holding a registration under ATC V08CA12 (gadopiclenol), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Gadopiclenol · ATC V08CA12

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
GADOPICLÉNOL
Manufacturer
GUERBET
Country
France (FR)
ATC code
V08CA12
ATC class
Gadopiclenol
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 7

  • cip13
    3400930283615
    1 flacon(s) en verre de 3 ml
  • cip13
    3400930283622
    1 flacon(s) en verre de 7,5 ml
  • cip13
    3400930283653
    1 flacon(s) en verre de 10 ml
  • cip13
    3400930283691
    1 flacon(s) en verre de 30 ml
  • cip13
    3400930283714
    1 flacon(s) en verre de 50 ml
  • cip13
    3400930283738
    1 seringue(s) préremplie(s) polypropylène de 7,5 ml
  • cip13
    3400930283783
    1 seringue(s) préremplie(s) polypropylène de 10 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Gadopiclenol in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gadopiclenol products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Elucirem
  • Iceland · Elucirem
  • Norway · Elucirem, Vueway

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/37aed424-f4e0-427e-9bb2-497600a1452f
GET /v1/drugs/37aed424-f4e0-427e-9bb2-497600a1452f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69770042",
  "date_amm": "2023-12-07",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/23/1772",
  "substance": "GADOPICLÉNOL",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

See everything about gadopiclenol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.